148 related articles for article (PubMed ID: 20626380)
1. Underutilization of gastroprotection for at-risk patients undergoing percutaneous coronary intervention: Spain compared with the United States.
Casado-Arroyo R; Scheiman JM; Polo-Tomas M; Saini SD; Del Rio A; Guastello E; Lanas A
Aliment Pharmacol Ther; 2010 Sep; 32(5):689-95. PubMed ID: 20626380
[TBL] [Abstract][Full Text] [Related]
2. [Does dual antiplatelet therapy always require gastroprotection? Gastroprotection with proton pump inhibitors is advisable for all patients who need dual antiplatelet therapy].
Morini S; Zullo A
G Ital Cardiol (Rome); 2010 Jun; 11(6):488-92; discussion 492. PubMed ID: 20922875
[No Abstract] [Full Text] [Related]
3. Proton pump inhibitors reduce the long-term risk of recurrent upper gastrointestinal bleeding: an observational study.
Massó González EL; García Rodríguez LA
Aliment Pharmacol Ther; 2008 Sep; 28(5):629-37. PubMed ID: 18616644
[TBL] [Abstract][Full Text] [Related]
4. PPI use in patients commenced on clopidogrel: a retrospective cross-sectional evaluation.
Luinstra M; Naunton M; Peterson GM; Bereznicki L
J Clin Pharm Ther; 2010 Apr; 35(2):213-7. PubMed ID: 20456741
[TBL] [Abstract][Full Text] [Related]
5. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN
Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493
[TBL] [Abstract][Full Text] [Related]
6. Effect of antisecretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulants.
Lanas A; García-Rodríguez LA; Arroyo MT; Bujanda L; Gomollón F; Forné M; Aleman S; Nicolas D; Feu F; González-Pérez A; Borda A; Castro M; Poveda MJ; Arenas J;
Am J Gastroenterol; 2007 Mar; 102(3):507-15. PubMed ID: 17338735
[TBL] [Abstract][Full Text] [Related]
7. Underutilization of gastroprotective strategies in aspirin users at increased risk of upper gastrointestinal complications.
Targownik LE; Metge CJ; Leung S
Aliment Pharmacol Ther; 2008 Jul; 28(1):88-96. PubMed ID: 18410563
[TBL] [Abstract][Full Text] [Related]
8. Use of physician education and computer alert to improve targeted use of gastroprotection among NSAID users.
Coté GA; Rice JP; Bulsiewicz W; Norvell JP; Christensen K; Bobb A; Postelnick M; Howden CW
Am J Gastroenterol; 2008 May; 103(5):1097-103. PubMed ID: 18477341
[TBL] [Abstract][Full Text] [Related]
9. Gastrointestinal bleeding associated with low-dose aspirin use: relevance and management in clinical practice.
Lanas A
Expert Opin Drug Saf; 2011 Jan; 10(1):45-54. PubMed ID: 20645883
[TBL] [Abstract][Full Text] [Related]
10. Continuous proton pump inhibitor treatment decreases upper gastrointestinal bleeding and related death in rural area in Japan.
Miyamoto M; Haruma K; Okamoto T; Higashi Y; Hidaka T; Manabe N
J Gastroenterol Hepatol; 2012 Feb; 27(2):372-7. PubMed ID: 21793917
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of differences between indication and prescription of gastroprotection in patients with risk factors treated with nonsteroidal anti-inflammatory agents: the GAP study].
Lanas A; Muñoz M; Caballero Correa M; Martínez Jiménez P;
Gastroenterol Hepatol; 2010 Feb; 33(2):80-91. PubMed ID: 19931944
[TBL] [Abstract][Full Text] [Related]
12. Management of patients with high gastrointestinal risk on antiplatelet therapy.
Cryer B
Gastroenterol Clin North Am; 2009 Jun; 38(2):289-303. PubMed ID: 19446259
[TBL] [Abstract][Full Text] [Related]
13. Proton pump inhibitors and risk of upper gastrointestinal bleeding in NSAID users.
Ibáñez L; Vidal X; Laporte JR
Am J Gastroenterol; 2008 Oct; 103(10):2658-9. PubMed ID: 18855866
[No Abstract] [Full Text] [Related]
14. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs.
Pilotto A; Franceschi M; Leandro G; Paris F; Cascavilla L; Longo MG; Niro V; Andriulli A; Scarcelli C; Di Mario F
Aliment Pharmacol Ther; 2004 Nov; 20(10):1091-7. PubMed ID: 15569111
[TBL] [Abstract][Full Text] [Related]
15. The prevalence of risk factors for gastrointestinal complications and use of gastroprotection among persons hospitalized for cardiovascular disease.
Targownik LE; Al-Mamfud A
Aliment Pharmacol Ther; 2006 Mar; 23(6):743-9. PubMed ID: 16556176
[TBL] [Abstract][Full Text] [Related]
16. Use of gastroprotection in patients discharged from hospital on nonsteroidal anti-inflammatory drugs.
Coté GA; Norvell JP; Rice JP; Bulsiewicz WJ; Howden CW
Am J Ther; 2008; 15(5):444-9. PubMed ID: 18806520
[TBL] [Abstract][Full Text] [Related]
17. [Does dual antiplatelet therapy always require gastroprotection? Tailored medical therapy should prevail over the generalized prescription of proton pump inhibitors in patients on dual antiplatelet therapy].
Marcucci R
G Ital Cardiol (Rome); 2010 Jun; 11(6):481-7; discussion 487. PubMed ID: 20922874
[No Abstract] [Full Text] [Related]
18. Cost-effectiveness of proton pump inhibitor cotherapy in patients taking long-term, low-dose aspirin for secondary cardiovascular prevention.
Saini SD; Schoenfeld P; Fendrick AM; Scheiman J
Arch Intern Med; 2008 Aug; 168(15):1684-90; discussion 1691. PubMed ID: 18695083
[TBL] [Abstract][Full Text] [Related]
19. Co-prescription of gastro-protectants in hospitalized patients: an analysis of what we do and what we think we do.
Doherty GA; Cannon MD; Lynch KM; Ayoubi KZ; Harewood GC; Patchett SE; Murray FE
J Clin Gastroenterol; 2010 Mar; 44(3):e51-6. PubMed ID: 19609216
[TBL] [Abstract][Full Text] [Related]
20. Nitrovasodilators, low-dose aspirin, other nonsteroidal antiinflammatory drugs, and the risk of upper gastrointestinal bleeding.
Lanas A; Bajador E; Serrano P; Fuentes J; Carreño S; Guardia J; Sanz M; Montoro M; Sáinz R
N Engl J Med; 2000 Sep; 343(12):834-9. PubMed ID: 10995862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
